RadNet, Inc.
$57.85
▼
-0.94%
2026-04-21 09:05:02
www.radnet.com
NGM: RDNT
Explore RadNet, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.48 B
Current Price
$57.85
52W High / Low
$85.84 / $46.76
Stock P/E
—
Book Value
$14.08
Dividend Yield
—
ROCE
2.63%
ROE
1.37%
Face Value
—
EPS
$-0.25
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
8,844
Beta
1.53
Debt / Equity
137.09
Current Ratio
1.76
Quick Ratio
1.76
Forward P/E
54.88
Price / Sales
2.11
Enterprise Value
$5.66 B
EV / EBITDA
23.3
EV / Revenue
2.77
Rating
None
Target Price
$92.38
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | BillionToOne, Inc. | $86.97 | 489.81 | $3.65 B | — | 2.74% | 2.3% | $138.7 / $61.96 | $10.48 |
| 2. | Insight Molecular Diagnostics Inc. | $3.99 | — | $128.35 M | — | -223.51% | 229.65% | $8.51 / $2.33 | $-1.1 |
| 3. | Advanced Biomed Inc. | $5 | 1.49 | $6.55 M | — | — | 80.18% | $48.8 / $3.61 | $8.76 |
| 4. | Qiagen N.V. | NOT FOUND | — | — | 0.64% | 9.02% | 11.57% | $57.81 / $38.8 | $18.33 |
| 5. | XWELL, Inc. | $1.2 | — | $9.7 M | — | -75.03% | -275.96% | $2.2 / $0.26 | $-1.1 |
| 6. | FONAR Corporation | $18.8 | 15.61 | $117.93 M | — | 5.81% | 6.01% | $18.86 / $12 | $27.01 |
| 7. | Danaher Corporation | $189.21 | 37.67 | $133.79 B | 0.82% | 6.12% | 7.05% | $242.8 / $180.03 | $74.32 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 547.71 M | 522.87 M | 498.23 M | 471.4 M | 477.1 M | — |
| Operating Profit | 35.08 M | 32.69 M | 33.15 M | -17.56 M | 29.65 M | — |
| Net Profit | -0.6 M | 5.42 M | 14.45 M | -37.93 M | 5.34 M | — |
| EPS in Rs | -0.01 | 0.07 | 0.19 | -0.49 | 0.07 | 0.04 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.04 B | 1.83 B | 1.62 B | 1.43 B |
| Operating Profit | 83.36 M | 111.28 M | 93 M | 49.84 M |
| Net Profit | -18.65 M | 2.79 M | 3.04 M | 10.65 M |
| EPS in Rs | -0.24 | 0.04 | 0.04 | 0.14 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.76 B | 3.29 B | 2.69 B | 2.43 B |
| Total Liabilities | 2.4 B | 2.15 B | 1.88 B | 1.94 B |
| Equity | 1.09 B | 902.31 M | 630.7 M | 333 M |
| Current Assets | 1.03 B | 1.02 B | 579.28 M | 367.18 M |
| Current Liabilities | 586.76 M | 479.71 M | 437.45 M | 466.72 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 298.82 M | 233.02 M | 220.86 M | 146.42 M |
| Investing CF | -343.87 M | -233.07 M | -201.47 M | -246.95 M |
| Financing CF | 72.21 M | 397.95 M | 195.63 M | 93.65 M |
| Free CF | 85.57 M | 44.95 M | 44.26 M | 26.97 M |
| Capex | -213.25 M | -188.07 M | -176.6 M | -119.45 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 13.18% | 13.05% | — | — |
| Earnings Growth % | -8.25% | -71.42% | — | — |
| Profit Margin % | 0.15% | 0.19% | 0.74% | — |
| Operating Margin % | 6.08% | 5.75% | 3.49% | — |
| Gross Margin % | 13.62% | 13.69% | 11.59% | — |
| EBITDA Margin % | 17.66% | 18.11% | 19.48% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.